Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice
Study Identifier
P10-681
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18+ years
Protocol Summary
The purpose of this study is to obtain data on the safety and effectiveness of Zemplar® (paricalcitol) injection and paricalcitol capsules in real-life clinical practice. Participants, who have been treated with paricalcitol in-label in an everyday setting, have been included into this study. A period of 12 months has been chosen in order to also obtain experience on the maintenance dose and treatment optimization with paricalcitol injection and paricalcitol capsules in long-term use.
Study Locations
Location
Status
Location
Site Reference ID/Investigator# 64522
Feldkirch, Austria, 6800
Status
Not applicable
Location
Site Reference ID/Investigator# 53506
Graz, Austria, 8010
Status
Not applicable
Location
Site Reference ID/Investigator# 53524
Graz, Austria, 8036
Status
Not applicable
Location
Site Reference ID/Investigator# 74733
Innsbruck, Austria, 6020
Status
Not applicable
Location
Site Reference ID/Investigator# 64523
Rottenmann, Austria, 8786
Status
Not applicable
Location
Site Reference ID/Investigator# 53525
Salzburg, Austria, 5020
Status
Not applicable
Showing {first} - {last} of {total} Results